Sanofi takes 26.4% stake in Cheplapharm in mature medicines partnership
SNY•Sanofi takes stake in Cheplapharm as part of mature medicines partnership
- Sanofi agreed to take a 26.4% equity stake in Cheplapharm as part of a planned mature-medicines strategic partnership.
- The equity investment is tied to Cheplapharm’s takeover of 20 mature medicines from Sanofi, including Lovenox/Clexane, excluding the US.
- The transaction also covers the planned transfer of three manufacturing sites in Hungary, Singapore, and France, with completion targeted by Q3 2027.
